The aim of the present study was to evaluate the capacity of a mifepristone/temozolomide treatment in an orthotopic rat model of glioblastoma to modulate angiogenesis, reduce P-gp levels in the glioma tumors and increase the intracerebral concentration of temozolomide. Here, PGP is linked to glioblastoma.